A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention
David J. Moliterno(University of Kentucky), James E. Tcheng(Duke University), Glenn N. Levine(American College of Cardiology), Ronald A. Stine(Sentara Norfolk General Hospital), Tift Mann(Unknown), Cindy L. Grines(Northside Hospital), Neal S. Kleiman(Houston Methodist), Eric J. Dippel(Trinity Medical Center), Steven J. Yacubov(Riverside Methodist Hospital), Robert J. Applegate(Wake Forest University), Gregory A. Braden(Wake Forest University), Ravi Nair(Biogen (United States)), Mark I. Furman, James Hermiller(St. Vincent Hospital), Dean J. Kereiakes(Health Net), Eric Yow(Duke University)
Cited by 44
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k